259 - Diagnostic Clinical Cases: What Do I Do With This Test Result?

Saturday, October 14, 2023

1:45 PM – 3:00 PM US ET

Location: 205 ABC

All relevant financial disclosures have been mitigated.

Moderator(s)

Dean Winslow, MD

Professor of Medicine
Stanford University
Stanford, CA, United States

Interactive Moderator(s)

Esther Babady, PhD (she/her/hers)

Chief, Clinical Microbiology Service
Laboratory Medicine
Memorial Sloan Kettering
New York, NY, United States
Thea Brennan-Krohn, MD, D(ABMM) (she/her/hers)

Assistant Professor of Pediatrics and Pathology
Harvard Medical School
Boston, MA, United States

Panelist(s)

Amy Mathers, MD, D(ABMM) (she/her/hers)

Associate Professor of Medicine and Pathology
University of Virginia
Charlottesville, VA, United States
Cynthia Nguyen, PharmD, BCIDP

Infectious Diseases Clinical Pharmacy Specialist
University of Chicago Medicine
Chicago, IL, United States
Ferric Fang, MD

Professor
Department of Laboratory Medicine and Pathology
University of Washington
Seattle, WA, United States
Lars Westblade, PhD

Clinical Microbiology Laboratory Director/Associate Professor
Pathology and Laboratory Medicine
Weill Cornell Medicine
New York, NY, United States

Disclosure(s):

Dean L. Winslow, MD: No financial relationships to disclose

Esther Babady, PhD: Copan Diagnostics: Grant/Research Support (Ongoing), Honoraria (Ongoing)

Thea Brennan-Krohn, MD, D(ABMM): No financial relationships to disclose

Amy Mathers, MD, D(ABMM): Cepheid, Inc: Advisor/Consultant (Ongoing); DayZeroDiagnositics: Advisor/Consultant (Ongoing); Melinta Therapuetics: Advisor/Consultant (Ongoing); Merck and Co: Advisor/Consultant (Ongoing); Op Gen: Advisor/Consultant (Ongoing); Qpex Biopharma: Advisor/Consultant (Ongoing); Venatorx Pharmaceuticals, Inc.: Advisor/Consultant (Ongoing)

Cynthia T. Nguyen, PharmD, BCIDP: Roche Diagnostics: Advisor/Consultant (Terminated, December 31, 2022)

Stan Deresinski, MD, FACP, FIDSA: No financial relationships to disclose

Ferric Fang, MD: bioMerieux Inc.: Advisor/Consultant (Ongoing); saNOtize: Board Member (Ongoing)

Lars Westblade, PhD: Accelerate Diagnostics, Inc: Grant/Research Support (Terminated); bioMerieux Inc.: Grant/Research Support (Terminated); Hardy Diagnostics: Grant/Research Support (Terminated); Roche Molecular Systems, Inc.: Advisor/Consultant (Terminated), Grant/Research Support (Terminated); Selux Diagnostics, Inc.: Grant/Research Support (Ongoing); Shionogi, Inc.: Advisor/Consultant (Terminated); Talis Biomedical: Advisor/Consultant (Terminated)

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-0000-23-002-L01-P

Learning Objectives:

At the conclusion of this session, participants will be able to:

explain the utility and limitations of diagnostic tests in clinical decision making;
explain positive and negative predictive value;
describe test results in light of pretest probability of disease